Risk factors and treatment outcomes for children with arterial ischemic stroke

Journal of Clinical Neuroscience

Volumn 17, Issue 8, 2010, Pages 1000-1002

  Incecik, Faruk ^a   Ozlem Herguner M ^a   Altunbasak, Sakir ^a  

^a CUKUROVA UNIVERSITY   (Turkey)

Author keywords

Childhood; Ischemic stroke; Risk factors

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ADOLESCENT; ANOXIA; AORTA ARCH SYNDROME; ARTICLE; BRAIN ISCHEMIA; CHILD; CLINICAL FEATURE; DEHYDRATION; DERMATOMYOSITIS; FAMILY HISTORY; FEMALE; HEART DISEASE; HOSPITAL ADMISSION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INFANT; INFECTION; INJURY; MAJOR CLINICAL STUDY; MALE; MELAS SYNDROME; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEIN S DEFICIENCY; RECURRENT DISEASE; RISK FACTOR; SEIZURE; SICKLE CELL ANEMIA; STROKE; THALASSEMIA MAJOR; TREATMENT OUTCOME; TURKEY (BIRD); CENTRAL NERVOUS SYSTEM INFECTION; COMPLICATION; CONGENITAL HEART MALFORMATION; INTRACRANIAL ARTERIAL DISEASES; PRESCHOOL CHILD;

ADOLESCENT; BRAIN ISCHEMIA; CENTRAL NERVOUS SYSTEM INFECTIONS; CHILD; CHILD, PRESCHOOL; FEMALE; HEART DEFECTS, CONGENITAL; HUMANS; INFANT; INTRACRANIAL ARTERIAL DISEASES; MALE; RISK FACTORS; STROKE; TREATMENT OUTCOME;

EID: 77953870587     PISSN: 09675868     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jocn.2010.01.004     Document Type: Article

References (17)

1. de Veber G., Roach E.S., Riela A.R., et al. Stroke in children: recognition, treatment, and future directions. Semin Pediatr Neurol 7 (2000) 309-317
2. Chung B., and Wong V. Pediatric stroke among Hong Kong Chinese subjects. Pediatrics 114 (2004) 206-212
3. Giroud M., Lemesle M., Gouyon J.B., et al. Cerebrovascular disease in children under 16 years of age in the city of Dijon, France: a study of incidence and clinical features from 1985 to 1993. J Clin Epidemiol 48 (1995) 1343-1348
4. Nowak-Gotti U., Strater R., Heinecke A., et al. Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin and methylenetetrahydrofolate reductase are risk factors of spontaneous ischemic stroke in childhood. Blood 94 (1999) 3678-3682
5. Ganesan V., and Kirkham F.J. Recurrence after ischaemic stroke in childhood. Dev Med Child Neurol Suppl. 79 (1998) 7
6. Earley C.J., Kittner S.J., Feeser B.R., et al. Stroke in children and sickle-cell disease: Baltimore-Washington Cooperative Young Stroke Study. Neurology 51 (1998) 169-176
7. Kenet G., Sadetzki S., Murad H., et al. Factor V Leiden and antiphospholipid antibodies are significant risk factors for ischemic stroke in children. Stroke 31 (2000) 1283-1288
8. Ganesan V., Prengler M., Mcshane M.A., et al. Investigation of risk factors in children with arterial ischemic stroke. Ann Neurol 53 (2003) 167-173
9. De Veber G. Canadian pediatric ischemic stroke study group. Canadian pediatric ischemic stroke registry: analysis of children with arterial ischemic stroke. Ann Neurol 48 (2000) 514
10. Chabrier S., Husson B., Lasjaunias P., et al. Stroke in childhood: outcome and recurrence risk by mechanism in 59 patients. J Child Neurol 15 (2000) 290-294
11. Kýrkham F.J., Prengler M., Hewes D.K., et al. Risk factors for arterial ischemic stroke in children. J Child Neurol 15 (2000) 299-307
12. Al Jarallah A., Al Rifai M.T., Riela A.R., et al. Non-traumatic brain hemorrhage in children: etiology, presentation. J Child Neurol 15 (2000) 284
13. Portnoy B.A., and Herion J.C. Neurological manifestations in sickle cell disease: with a review of the literature and emphasis on the prevalence of hemiplegia. Ann Intern Med 76 (1972) 643-652
14. Salih M.A., Abdel-Gader A.G., Al-Jarallah A.A., et al. Hematologic risk factors for stroke in Saudi children. Saudi Med J 23 Suppl. 1 (2006) S21-S34
15. Takeoka M., and Takahashi T. Infections and inflammatory disorders of the circulatory system and stroke in childhood. Curr Opin Neurol 15 (2002) 159-164
16. Lindsberg P.J., and Grau A.J. Inflammation and infections as risk factors for ischemic stroke. Stroke 34 (2003) 2518-2532
17. Simma B., Martin G., Müller T., et al. Risk factors for pediatric stroke: consequences for therapy and quality of life. Pediatr Neurol 37 (2007) 121-126